0000014272-16-000415.txt : 20160510 0000014272-16-000415.hdr.sgml : 20160510 20160510163555 ACCESSION NUMBER: 0000014272-16-000415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160506 FILED AS OF DATE: 20160510 DATE AS OF CHANGE: 20160510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEUNG SANDRA CENTRAL INDEX KEY: 0001199294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 161636286 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 4 1 wf-form4_146291254024914.xml FORM 4 X0306 4 2016-05-06 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001199294 LEUNG SANDRA BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 EVP, General Counsel Common Stock, $0.10 par value 2016-05-06 4 M 0 100000 24.74 A 444507.3322 D Common Stock, $0.10 par value 2016-05-06 4 S 0 72544 70.39 D 371963.3322 D Common Stock, $0.10 par value 5738.8795 I By BMY Savings and Investment Program Option (right to buy) 24.74 2016-05-06 4 M 0 100000 0 D 2016-11-30 Common Stock, $0.10 par value 100000.0 0 D A portion of these shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $70.35 to $70.48, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Based on a plan statement as of the end of the most recent fiscal quarter All of the shares are currently exercisable. /s/ Katherine Kelly, attorney-in-fact for Sandra Leung 2016-05-10